Israel Expands Non-Small Cell Lung Cancer Testing Coverage
Israeli laboratories are approved to use molecular profiling assays for NSCLC patients using Thermo Fisher Scientific’s Oncomine Comprehensive Assay Plus.
Read MorePosted by Melanie Hamilton-Basich | Jul 29, 2020 | Lung Cancer, Molecular Diagnostics |
Israeli laboratories are approved to use molecular profiling assays for NSCLC patients using Thermo Fisher Scientific’s Oncomine Comprehensive Assay Plus.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Analytical Software Systems, Information Technology |
Roche’s algorithm provides automated assessments of scanned slide images that are objective and reproducible and have the potential to aid diagnosis.
Read MorePosted by Steve Halasey | Oct 15, 2019 | Immunoassay, Lung Cancer |
The Early Detection for Cancer of the Lung Scotland trial is believed to be the world’s largest trial for the detection of lung cancer using biomarkers.
Read MorePosted by Steve Halasey | Aug 26, 2019 | Lung Cancer |
Multigene panels would deliver greater value if patients with actionable genetic mutations consistently received guided treatments.
Read MorePosted by Chaunie Brusie | Apr 18, 2019 | Lung Cancer |
The tests will use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases.
Read More